nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Daunorubicin—hematologic cancer	0.113	0.226	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Teniposide—hematologic cancer	0.0962	0.192	CiPCiCtD
Irinotecan—TOP1—hematologic cancer	0.0859	0.49	CbGaD
Irinotecan—Topoisomerase Inhibitors—Idarubicin—hematologic cancer	0.0857	0.171	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Mitoxantrone—hematologic cancer	0.0729	0.145	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Etoposide—hematologic cancer	0.0572	0.114	CiPCiCtD
Irinotecan—UGT1A1—hematologic cancer	0.0438	0.25	CbGaD
Irinotecan—Topoisomerase Inhibitors—Epirubicin—hematologic cancer	0.0394	0.0786	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—hematologic cancer	0.0364	0.0727	CiPCiCtD
Irinotecan—ABCG2—hematologic cancer	0.0246	0.14	CbGaD
Irinotecan—SLC22A3—Melphalan—hematologic cancer	0.0134	0.0677	CbGbCtD
Irinotecan—ALB—hematologic cancer	0.0107	0.0612	CbGaD
Irinotecan—ABCB1—hematologic cancer	0.0102	0.0584	CbGaD
Irinotecan—ABCC1—Idarubicin—hematologic cancer	0.00875	0.0442	CbGbCtD
Irinotecan—ABCG2—Clofarabine—hematologic cancer	0.00706	0.0357	CbGbCtD
Irinotecan—ABCC1—Daunorubicin—hematologic cancer	0.00619	0.0313	CbGbCtD
Irinotecan—UGT1A1—Nilotinib—hematologic cancer	0.00524	0.0265	CbGbCtD
Irinotecan—ABCC2—Daunorubicin—hematologic cancer	0.00458	0.0231	CbGbCtD
Irinotecan—ABCG2—Daunorubicin—hematologic cancer	0.00414	0.0209	CbGbCtD
Irinotecan—CYP2B6—Thiotepa—hematologic cancer	0.00412	0.0208	CbGbCtD
Irinotecan—SLC22A3—Vincristine—hematologic cancer	0.00396	0.02	CbGbCtD
Irinotecan—ABCC1—Mitoxantrone—hematologic cancer	0.00376	0.019	CbGbCtD
Irinotecan—BCHE—Triamcinolone—hematologic cancer	0.00371	0.0188	CbGbCtD
Irinotecan—ABCG2—Teniposide—hematologic cancer	0.0036	0.0182	CbGbCtD
Irinotecan—ABCG2—Cladribine—hematologic cancer	0.00345	0.0174	CbGbCtD
Irinotecan—ABCG2—Imatinib—hematologic cancer	0.00317	0.016	CbGbCtD
Irinotecan—ABCC1—Epirubicin—hematologic cancer	0.00304	0.0154	CbGbCtD
Irinotecan—UGT1A1—Etoposide—hematologic cancer	0.00288	0.0146	CbGbCtD
Irinotecan—ABCG2—Nilotinib—hematologic cancer	0.00288	0.0146	CbGbCtD
Irinotecan—ABCC1—Vinblastine—hematologic cancer	0.00263	0.0133	CbGbCtD
Irinotecan—ABCC1—Vincristine—hematologic cancer	0.00259	0.0131	CbGbCtD
Irinotecan—ABCG2—Dasatinib—hematologic cancer	0.00255	0.0129	CbGbCtD
Irinotecan—ABCB1—Lenalidomide—hematologic cancer	0.00255	0.0129	CbGbCtD
Irinotecan—ABCG2—Mitoxantrone—hematologic cancer	0.00252	0.0127	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00245	0.0124	CbGbCtD
Irinotecan—CYP3A7—Ifosfamide—hematologic cancer	0.00245	0.0124	CbGbCtD
Irinotecan—ABCC1—Etoposide—hematologic cancer	0.00237	0.012	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00234	0.0118	CbGbCtD
Irinotecan—CYP3A7—Imatinib—hematologic cancer	0.00234	0.0118	CbGbCtD
Irinotecan—CYP2B6—Ifosfamide—hematologic cancer	0.00234	0.0118	CbGbCtD
Irinotecan—BCHE—Cisplatin—hematologic cancer	0.00229	0.0116	CbGbCtD
Irinotecan—CYP3A5—Daunorubicin—hematologic cancer	0.00229	0.0116	CbGbCtD
Irinotecan—ALB—Imatinib—hematologic cancer	0.00219	0.011	CbGbCtD
Irinotecan—CYP3A5—Thalidomide—hematologic cancer	0.00209	0.0106	CbGbCtD
Irinotecan—CYP2B6—Nilotinib—hematologic cancer	0.00203	0.0102	CbGbCtD
Irinotecan—CYP3A5—Teniposide—hematologic cancer	0.00199	0.0101	CbGbCtD
Irinotecan—ABCC2—Vinblastine—hematologic cancer	0.00195	0.00985	CbGbCtD
Irinotecan—ABCC2—Vincristine—hematologic cancer	0.00192	0.00968	CbGbCtD
Irinotecan—CYP3A5—Ifosfamide—hematologic cancer	0.00184	0.0093	CbGbCtD
Irinotecan—ABCC2—Cisplatin—hematologic cancer	0.00179	0.00903	CbGbCtD
Irinotecan—CYP3A5—Imatinib—hematologic cancer	0.00176	0.00888	CbGbCtD
Irinotecan—ABCC2—Etoposide—hematologic cancer	0.00176	0.00887	CbGbCtD
Irinotecan—ABCG2—Vincristine—hematologic cancer	0.00173	0.00875	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—hematologic cancer	0.00162	0.00817	CbGbCtD
Irinotecan—ABCG2—Cisplatin—hematologic cancer	0.00161	0.00816	CbGbCtD
Irinotecan—ABCG2—Etoposide—hematologic cancer	0.00159	0.00802	CbGbCtD
Irinotecan—ABCC1—Methotrexate—hematologic cancer	0.00157	0.00792	CbGbCtD
Irinotecan—CYP3A4—Bexarotene—hematologic cancer	0.00153	0.00771	CbGbCtD
Irinotecan—ABCB1—Daunorubicin—hematologic cancer	0.00149	0.00755	CbGbCtD
Irinotecan—ABCB1—Alitretinoin—hematologic cancer	0.00146	0.00739	CbGbCtD
Irinotecan—ABCC2—Dexamethasone—hematologic cancer	0.00144	0.00729	CbGbCtD
Irinotecan—ALB—Prednisone—hematologic cancer	0.00144	0.00728	CbGbCtD
Irinotecan—CYP3A4—Lomustine—hematologic cancer	0.00142	0.00717	CbGbCtD
Irinotecan—CYP3A4—Busulfan—hematologic cancer	0.00142	0.00717	CbGbCtD
Irinotecan—CYP3A5—Dasatinib—hematologic cancer	0.00141	0.00713	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—hematologic cancer	0.00132	0.00667	CbGbCtD
Irinotecan—ABCG2—Dexamethasone—hematologic cancer	0.0013	0.00659	CbGbCtD
Irinotecan—CYP3A7—Vincristine—hematologic cancer	0.00128	0.00646	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00128	0.00646	CbGbCtD
Irinotecan—CYP3A4—Thiotepa—hematologic cancer	0.00126	0.00639	CbGbCtD
Irinotecan—Topotecan—TOP1—hematologic cancer	0.00122	0.712	CrCbGaD
Irinotecan—ABCC2—Doxorubicin—hematologic cancer	0.0012	0.00605	CbGbCtD
Irinotecan—ABCC2—Methotrexate—hematologic cancer	0.00116	0.00586	CbGbCtD
Irinotecan—ABCB1—Imatinib—hematologic cancer	0.00114	0.00578	CbGbCtD
Irinotecan—CYP2B6—Cisplatin—hematologic cancer	0.00114	0.00574	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—hematologic cancer	0.00108	0.00547	CbGbCtD
Irinotecan—ABCG2—Methotrexate—hematologic cancer	0.00105	0.0053	CbGbCtD
Irinotecan—ABCB1—Nilotinib—hematologic cancer	0.00104	0.00525	CbGbCtD
Irinotecan—ABCB1—Vinorelbine—hematologic cancer	0.00103	0.00521	CbGbCtD
Irinotecan—CYP3A4—Methoxsalen—hematologic cancer	0.000983	0.00497	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.000964	0.00487	CbGbCtD
Irinotecan—CYP3A7—Dexamethasone—hematologic cancer	0.000964	0.00487	CbGbCtD
Irinotecan—CYP3A5—Vincristine—hematologic cancer	0.000959	0.00485	CbGbCtD
Irinotecan—CYP3A4—Bortezomib—hematologic cancer	0.000935	0.00473	CbGbCtD
Irinotecan—ABCB1—Dasatinib—hematologic cancer	0.000919	0.00464	CbGbCtD
Irinotecan—CYP2B6—Dexamethasone—hematologic cancer	0.000918	0.00464	CbGbCtD
Irinotecan—ABCB1—Mitoxantrone—hematologic cancer	0.000907	0.00459	CbGbCtD
Irinotecan—CYP3A4—Daunorubicin—hematologic cancer	0.000895	0.00452	CbGbCtD
Irinotecan—CYP3A5—Etoposide—hematologic cancer	0.000879	0.00444	CbGbCtD
Irinotecan—ABCB1—Betamethasone—hematologic cancer	0.000809	0.00409	CbGbCtD
Irinotecan—ABCB1—Gemcitabine—hematologic cancer	0.000801	0.00405	CbGbCtD
Irinotecan—ABCB1—Prednisolone—hematologic cancer	0.000798	0.00403	CbGbCtD
Irinotecan—CYP3A4—Cytarabine—hematologic cancer	0.000789	0.00399	CbGbCtD
Irinotecan—TOP1MT—gonad—hematologic cancer	0.000785	0.055	CbGeAlD
Irinotecan—CYP3A4—Teniposide—hematologic cancer	0.000777	0.00393	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—hematologic cancer	0.000761	0.00385	CbGbCtD
Irinotecan—ABCB1—Prednisone—hematologic cancer	0.000754	0.00381	CbGbCtD
Irinotecan—CYP3A5—Dexamethasone—hematologic cancer	0.000723	0.00365	CbGbCtD
Irinotecan—ALB—Methotrexate—hematologic cancer	0.000723	0.00365	CbGbCtD
Irinotecan—CYP3A4—Ifosfamide—hematologic cancer	0.000717	0.00363	CbGbCtD
Irinotecan—CYP3A4—Imatinib—hematologic cancer	0.000685	0.00346	CbGbCtD
Irinotecan—CYP3A4—Ruxolitinib—hematologic cancer	0.000645	0.00326	CbGbCtD
Irinotecan—ABCB1—Vinblastine—hematologic cancer	0.000635	0.00321	CbGbCtD
Irinotecan—ABCB1—Vincristine—hematologic cancer	0.000624	0.00316	CbGbCtD
Irinotecan—CYP3A4—Nilotinib—hematologic cancer	0.000623	0.00315	CbGbCtD
Irinotecan—CYP3A4—Vinorelbine—hematologic cancer	0.000617	0.00312	CbGbCtD
Irinotecan—TOP1MT—lung—hematologic cancer	0.000599	0.042	CbGeAlD
Irinotecan—ABCB1—Cisplatin—hematologic cancer	0.000582	0.00294	CbGbCtD
Irinotecan—ABCB1—Etoposide—hematologic cancer	0.000572	0.00289	CbGbCtD
Irinotecan—TOP1MT—testis—hematologic cancer	0.000565	0.0396	CbGeAlD
Irinotecan—CYP3A4—Triamcinolone—hematologic cancer	0.000565	0.00285	CbGbCtD
Irinotecan—CYP3A4—Dasatinib—hematologic cancer	0.00055	0.00278	CbGbCtD
Irinotecan—CYP3A4—Mitoxantrone—hematologic cancer	0.000544	0.00275	CbGbCtD
Irinotecan—CES2—hematopoietic system—hematologic cancer	0.000494	0.0346	CbGeAlD
Irinotecan—CYP3A4—Betamethasone—hematologic cancer	0.000485	0.00245	CbGbCtD
Irinotecan—CYP3A4—Prednisolone—hematologic cancer	0.000478	0.00242	CbGbCtD
Irinotecan—ABCB1—Dexamethasone—hematologic cancer	0.00047	0.00238	CbGbCtD
Irinotecan—CYP3A4—Prednisone—hematologic cancer	0.000451	0.00228	CbGbCtD
Irinotecan—UGT1A1—hematopoietic system—hematologic cancer	0.00042	0.0294	CbGeAlD
Irinotecan—TOP1MT—lymph node—hematologic cancer	0.00041	0.0287	CbGeAlD
Irinotecan—CES1—hematopoietic system—hematologic cancer	0.000407	0.0285	CbGeAlD
Irinotecan—ABCB1—Doxorubicin—hematologic cancer	0.00039	0.00197	CbGbCtD
Irinotecan—CYP3A4—Vinblastine—hematologic cancer	0.000381	0.00192	CbGbCtD
Irinotecan—ABCB1—Methotrexate—hematologic cancer	0.000378	0.00191	CbGbCtD
Irinotecan—CES2—gonad—hematologic cancer	0.000375	0.0263	CbGeAlD
Irinotecan—CYP3A4—Vincristine—hematologic cancer	0.000374	0.00189	CbGbCtD
Irinotecan—TOP1—blood—hematologic cancer	0.000361	0.0253	CbGeAlD
Irinotecan—Topotecan—ABCG2—hematologic cancer	0.00035	0.204	CrCbGaD
Irinotecan—SLCO1B1—hematopoietic system—hematologic cancer	0.000349	0.0245	CbGeAlD
Irinotecan—TOP1—bone marrow—hematologic cancer	0.000349	0.0245	CbGeAlD
Irinotecan—CYP3A4—Etoposide—hematologic cancer	0.000343	0.00173	CbGbCtD
Irinotecan—CES2—blood—hematologic cancer	0.000327	0.0229	CbGeAlD
Irinotecan—CES2—bone marrow—hematologic cancer	0.000316	0.0222	CbGeAlD
Irinotecan—TOP1—lung—hematologic cancer	0.000316	0.0222	CbGeAlD
Irinotecan—TOP1—testis—hematologic cancer	0.000298	0.0209	CbGeAlD
Irinotecan—CES2—lung—hematologic cancer	0.000287	0.0201	CbGeAlD
Irinotecan—SLC22A3—hematopoietic system—hematologic cancer	0.000282	0.0198	CbGeAlD
Irinotecan—CYP3A4—Dexamethasone—hematologic cancer	0.000282	0.00142	CbGbCtD
Irinotecan—UGT1A1—blood—hematologic cancer	0.000278	0.0195	CbGeAlD
Irinotecan—CES2—testis—hematologic cancer	0.000271	0.019	CbGeAlD
Irinotecan—CES1—blood—hematologic cancer	0.000269	0.0189	CbGeAlD
Irinotecan—CES1—lung—hematologic cancer	0.000236	0.0166	CbGeAlD
Irinotecan—CYP3A4—Doxorubicin—hematologic cancer	0.000234	0.00118	CbGbCtD
Irinotecan—SLCO1B1—blood—hematologic cancer	0.000231	0.0162	CbGeAlD
Irinotecan—CES1—testis—hematologic cancer	0.000223	0.0156	CbGeAlD
Irinotecan—ACHE—testis—hematologic cancer	0.000223	0.0156	CbGeAlD
Irinotecan—TOP1—lymph node—hematologic cancer	0.000216	0.0152	CbGeAlD
Irinotecan—SLC22A3—gonad—hematologic cancer	0.000215	0.015	CbGeAlD
Irinotecan—BCHE—hematopoietic system—hematologic cancer	0.0002	0.014	CbGeAlD
Irinotecan—CES2—lymph node—hematologic cancer	0.000196	0.0137	CbGeAlD
Irinotecan—CYP3A5—hematopoietic system—hematologic cancer	0.000179	0.0126	CbGeAlD
Irinotecan—CYP2B6—hematopoietic system—hematologic cancer	0.000178	0.0125	CbGeAlD
Irinotecan—ABCC2—blood—hematologic cancer	0.000175	0.0123	CbGeAlD
Irinotecan—SLC22A3—lung—hematologic cancer	0.000164	0.0115	CbGeAlD
Irinotecan—ACHE—lymph node—hematologic cancer	0.000161	0.0113	CbGeAlD
Irinotecan—CES1—lymph node—hematologic cancer	0.000161	0.0113	CbGeAlD
Irinotecan—ALB—testis—hematologic cancer	0.000155	0.0109	CbGeAlD
Irinotecan—SLC22A3—testis—hematologic cancer	0.000155	0.0108	CbGeAlD
Irinotecan—ABCC1—blood—hematologic cancer	0.000155	0.0108	CbGeAlD
Irinotecan—Topotecan—ABCB1—hematologic cancer	0.000146	0.0848	CrCbGaD
Irinotecan—ABCC2—testis—hematologic cancer	0.000145	0.0102	CbGeAlD
Irinotecan—ABCC1—lung—hematologic cancer	0.000135	0.0095	CbGeAlD
Irinotecan—CYP2B6—gonad—hematologic cancer	0.000135	0.0095	CbGeAlD
Irinotecan—CYP3A4—hematopoietic system—hematologic cancer	0.000135	0.00943	CbGeAlD
Irinotecan—BCHE—blood—hematologic cancer	0.000132	0.00928	CbGeAlD
Irinotecan—BCHE—bone marrow—hematologic cancer	0.000128	0.00898	CbGeAlD
Irinotecan—ABCG2—blood—hematologic cancer	0.000128	0.00897	CbGeAlD
Irinotecan—ABCC1—testis—hematologic cancer	0.000128	0.00896	CbGeAlD
Irinotecan—ABCG2—bone marrow—hematologic cancer	0.000124	0.00868	CbGeAlD
Irinotecan—CYP3A5—blood—hematologic cancer	0.000119	0.00833	CbGeAlD
Irinotecan—CYP2B6—blood—hematologic cancer	0.000118	0.00827	CbGeAlD
Irinotecan—BCHE—lung—hematologic cancer	0.000116	0.00814	CbGeAlD
Irinotecan—ALB—lymph node—hematologic cancer	0.000112	0.00787	CbGeAlD
Irinotecan—ABCG2—lung—hematologic cancer	0.000112	0.00786	CbGeAlD
Irinotecan—SLC22A3—lymph node—hematologic cancer	0.000112	0.00786	CbGeAlD
Irinotecan—BCHE—testis—hematologic cancer	0.000109	0.00768	CbGeAlD
Irinotecan—ABCG2—testis—hematologic cancer	0.000106	0.00742	CbGeAlD
Irinotecan—ABCC2—lymph node—hematologic cancer	0.000105	0.00737	CbGeAlD
Irinotecan—CYP3A5—lung—hematologic cancer	0.000104	0.0073	CbGeAlD
Irinotecan—CYP2B6—lung—hematologic cancer	0.000103	0.00725	CbGeAlD
Irinotecan—CYP2B6—testis—hematologic cancer	9.76e-05	0.00684	CbGeAlD
Irinotecan—ABCB1—hematopoietic system—hematologic cancer	9.52e-05	0.00668	CbGeAlD
Irinotecan—ABCC1—lymph node—hematologic cancer	9.27e-05	0.0065	CbGeAlD
Irinotecan—CYP3A4—blood—hematologic cancer	8.91e-05	0.00625	CbGeAlD
Irinotecan—BCHE—lymph node—hematologic cancer	7.94e-05	0.00556	CbGeAlD
Irinotecan—ABCG2—lymph node—hematologic cancer	7.67e-05	0.00538	CbGeAlD
Irinotecan—ABCB1—gonad—hematologic cancer	7.24e-05	0.00508	CbGeAlD
Irinotecan—ABCB1—blood—hematologic cancer	6.31e-05	0.00442	CbGeAlD
Irinotecan—ABCB1—bone marrow—hematologic cancer	6.1e-05	0.00428	CbGeAlD
Irinotecan—ABCB1—lung—hematologic cancer	5.53e-05	0.00388	CbGeAlD
Irinotecan—ABCB1—testis—hematologic cancer	5.22e-05	0.00366	CbGeAlD
Irinotecan—ABCB1—lymph node—hematologic cancer	3.78e-05	0.00265	CbGeAlD
Irinotecan—Insomnia—Betamethasone—hematologic cancer	6.29e-06	8.28e-05	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—hematologic cancer	6.28e-06	8.27e-05	CcSEcCtD
Irinotecan—Paraesthesia—Dexamethasone—hematologic cancer	6.24e-06	8.22e-05	CcSEcCtD
Irinotecan—Paraesthesia—Betamethasone—hematologic cancer	6.24e-06	8.22e-05	CcSEcCtD
Irinotecan—Discomfort—Prednisone—hematologic cancer	6.24e-06	8.22e-05	CcSEcCtD
Irinotecan—Rash—Gemcitabine—hematologic cancer	6.24e-06	8.22e-05	CcSEcCtD
Irinotecan—Dermatitis—Gemcitabine—hematologic cancer	6.23e-06	8.21e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Etoposide—hematologic cancer	6.22e-06	8.2e-05	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—hematologic cancer	6.2e-06	8.17e-05	CcSEcCtD
Irinotecan—Headache—Gemcitabine—hematologic cancer	6.2e-06	8.16e-05	CcSEcCtD
Irinotecan—Nausea—Vincristine—hematologic cancer	6.19e-06	8.16e-05	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—hematologic cancer	6.18e-06	8.15e-05	CcSEcCtD
Irinotecan—Flushing—Epirubicin—hematologic cancer	6.18e-06	8.15e-05	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—hematologic cancer	6.18e-06	8.14e-05	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—hematologic cancer	6.17e-06	8.12e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisolone—hematologic cancer	6.14e-06	8.09e-05	CcSEcCtD
Irinotecan—Dyspepsia—Dexamethasone—hematologic cancer	6.12e-06	8.06e-05	CcSEcCtD
Irinotecan—Dyspepsia—Betamethasone—hematologic cancer	6.12e-06	8.06e-05	CcSEcCtD
Irinotecan—Asthenia—Etoposide—hematologic cancer	6.06e-06	7.98e-05	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—hematologic cancer	6.06e-06	7.98e-05	CcSEcCtD
Irinotecan—Body temperature increased—Triamcinolone—hematologic cancer	6.06e-06	7.98e-05	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisone—hematologic cancer	6.05e-06	7.98e-05	CcSEcCtD
Irinotecan—Oedema—Prednisone—hematologic cancer	6.05e-06	7.98e-05	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—hematologic cancer	6.05e-06	7.97e-05	CcSEcCtD
Irinotecan—Decreased appetite—Betamethasone—hematologic cancer	6.04e-06	7.96e-05	CcSEcCtD
Irinotecan—Decreased appetite—Dexamethasone—hematologic cancer	6.04e-06	7.96e-05	CcSEcCtD
Irinotecan—Nausea—Mitoxantrone—hematologic cancer	6.03e-06	7.95e-05	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—hematologic cancer	6.02e-06	7.93e-05	CcSEcCtD
Irinotecan—Infection—Prednisone—hematologic cancer	6.01e-06	7.92e-05	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—hematologic cancer	6.01e-06	7.91e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6e-06	7.91e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Betamethasone—hematologic cancer	6e-06	7.91e-05	CcSEcCtD
Irinotecan—Back pain—Methotrexate—hematologic cancer	6e-06	7.9e-05	CcSEcCtD
Irinotecan—Fatigue—Dexamethasone—hematologic cancer	5.99e-06	7.9e-05	CcSEcCtD
Irinotecan—Fatigue—Betamethasone—hematologic cancer	5.99e-06	7.9e-05	CcSEcCtD
Irinotecan—Chills—Epirubicin—hematologic cancer	5.98e-06	7.88e-05	CcSEcCtD
Irinotecan—Shock—Prednisone—hematologic cancer	5.96e-06	7.85e-05	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—hematologic cancer	5.95e-06	7.84e-05	CcSEcCtD
Irinotecan—Pain—Dexamethasone—hematologic cancer	5.94e-06	7.83e-05	CcSEcCtD
Irinotecan—Pain—Betamethasone—hematologic cancer	5.94e-06	7.83e-05	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—hematologic cancer	5.94e-06	7.83e-05	CcSEcCtD
Irinotecan—Nervous system disorder—Prednisone—hematologic cancer	5.94e-06	7.82e-05	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—hematologic cancer	5.89e-06	7.76e-05	CcSEcCtD
Irinotecan—Nausea—Gemcitabine—hematologic cancer	5.87e-06	7.74e-05	CcSEcCtD
Irinotecan—Vomiting—Cisplatin—hematologic cancer	5.86e-06	7.72e-05	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisone—hematologic cancer	5.85e-06	7.71e-05	CcSEcCtD
Irinotecan—Rash—Cisplatin—hematologic cancer	5.81e-06	7.66e-05	CcSEcCtD
Irinotecan—Dermatitis—Cisplatin—hematologic cancer	5.81e-06	7.65e-05	CcSEcCtD
Irinotecan—Diarrhoea—Etoposide—hematologic cancer	5.78e-06	7.61e-05	CcSEcCtD
Irinotecan—Anorexia—Prednisone—hematologic cancer	5.77e-06	7.6e-05	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—hematologic cancer	5.75e-06	7.58e-05	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—hematologic cancer	5.73e-06	7.55e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Betamethasone—hematologic cancer	5.73e-06	7.55e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Dexamethasone—hematologic cancer	5.73e-06	7.55e-05	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—hematologic cancer	5.72e-06	7.54e-05	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—hematologic cancer	5.72e-06	7.54e-05	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—hematologic cancer	5.72e-06	7.53e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Betamethasone—hematologic cancer	5.68e-06	7.49e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.68e-06	7.49e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Triamcinolone—hematologic cancer	5.64e-06	7.44e-05	CcSEcCtD
Irinotecan—Back pain—Epirubicin—hematologic cancer	5.61e-06	7.39e-05	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—hematologic cancer	5.59e-06	7.37e-05	CcSEcCtD
Irinotecan—Malaise—Methotrexate—hematologic cancer	5.59e-06	7.37e-05	CcSEcCtD
Irinotecan—Dizziness—Etoposide—hematologic cancer	5.58e-06	7.36e-05	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—hematologic cancer	5.58e-06	7.35e-05	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—hematologic cancer	5.57e-06	7.34e-05	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—hematologic cancer	5.57e-06	7.34e-05	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—hematologic cancer	5.56e-06	7.32e-05	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—hematologic cancer	5.55e-06	7.31e-05	CcSEcCtD
Irinotecan—Chills—Doxorubicin—hematologic cancer	5.53e-06	7.29e-05	CcSEcCtD
Irinotecan—Dizziness—Prednisolone—hematologic cancer	5.51e-06	7.26e-05	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—hematologic cancer	5.51e-06	7.26e-05	CcSEcCtD
Irinotecan—Asthenia—Triamcinolone—hematologic cancer	5.5e-06	7.24e-05	CcSEcCtD
Irinotecan—Abdominal pain—Dexamethasone—hematologic cancer	5.49e-06	7.24e-05	CcSEcCtD
Irinotecan—Body temperature increased—Betamethasone—hematologic cancer	5.49e-06	7.24e-05	CcSEcCtD
Irinotecan—Body temperature increased—Dexamethasone—hematologic cancer	5.49e-06	7.24e-05	CcSEcCtD
Irinotecan—Abdominal pain—Betamethasone—hematologic cancer	5.49e-06	7.24e-05	CcSEcCtD
Irinotecan—Nausea—Cisplatin—hematologic cancer	5.48e-06	7.22e-05	CcSEcCtD
Irinotecan—Insomnia—Prednisone—hematologic cancer	5.47e-06	7.21e-05	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—hematologic cancer	5.45e-06	7.18e-05	CcSEcCtD
Irinotecan—Paraesthesia—Prednisone—hematologic cancer	5.44e-06	7.16e-05	CcSEcCtD
Irinotecan—Cough—Methotrexate—hematologic cancer	5.41e-06	7.13e-05	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—hematologic cancer	5.38e-06	7.09e-05	CcSEcCtD
Irinotecan—Vomiting—Etoposide—hematologic cancer	5.37e-06	7.08e-05	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—hematologic cancer	5.36e-06	7.06e-05	CcSEcCtD
Irinotecan—Dyspepsia—Prednisone—hematologic cancer	5.33e-06	7.02e-05	CcSEcCtD
Irinotecan—Rash—Etoposide—hematologic cancer	5.32e-06	7.02e-05	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—hematologic cancer	5.32e-06	7.01e-05	CcSEcCtD
Irinotecan—Headache—Etoposide—hematologic cancer	5.29e-06	6.97e-05	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—hematologic cancer	5.29e-06	6.97e-05	CcSEcCtD
Irinotecan—Decreased appetite—Prednisone—hematologic cancer	5.26e-06	6.93e-05	CcSEcCtD
Irinotecan—Rash—Prednisolone—hematologic cancer	5.25e-06	6.92e-05	CcSEcCtD
Irinotecan—Dermatitis—Prednisolone—hematologic cancer	5.25e-06	6.91e-05	CcSEcCtD
Irinotecan—Malaise—Epirubicin—hematologic cancer	5.23e-06	6.89e-05	CcSEcCtD
Irinotecan—Fatigue—Prednisone—hematologic cancer	5.22e-06	6.88e-05	CcSEcCtD
Irinotecan—Headache—Prednisolone—hematologic cancer	5.22e-06	6.88e-05	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—hematologic cancer	5.21e-06	6.87e-05	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—hematologic cancer	5.21e-06	6.87e-05	CcSEcCtD
Irinotecan—Syncope—Epirubicin—hematologic cancer	5.2e-06	6.85e-05	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—hematologic cancer	5.19e-06	6.84e-05	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—hematologic cancer	5.19e-06	6.84e-05	CcSEcCtD
Irinotecan—Constipation—Prednisone—hematologic cancer	5.18e-06	6.82e-05	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—hematologic cancer	5.16e-06	6.8e-05	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—hematologic cancer	5.1e-06	6.72e-05	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—hematologic cancer	5.1e-06	6.72e-05	CcSEcCtD
Irinotecan—Dizziness—Triamcinolone—hematologic cancer	5.07e-06	6.67e-05	CcSEcCtD
Irinotecan—Cough—Epirubicin—hematologic cancer	5.06e-06	6.67e-05	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—hematologic cancer	5.06e-06	6.67e-05	CcSEcCtD
Irinotecan—Infection—Methotrexate—hematologic cancer	5.03e-06	6.62e-05	CcSEcCtD
Irinotecan—Nausea—Etoposide—hematologic cancer	5.02e-06	6.61e-05	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—hematologic cancer	5.01e-06	6.6e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisone—hematologic cancer	4.99e-06	6.57e-05	CcSEcCtD
Irinotecan—Asthenia—Betamethasone—hematologic cancer	4.99e-06	6.57e-05	CcSEcCtD
Irinotecan—Asthenia—Dexamethasone—hematologic cancer	4.99e-06	6.57e-05	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—hematologic cancer	4.98e-06	6.56e-05	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—hematologic cancer	4.96e-06	6.54e-05	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—hematologic cancer	4.96e-06	6.54e-05	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—hematologic cancer	4.95e-06	6.53e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Prednisone—hematologic cancer	4.95e-06	6.52e-05	CcSEcCtD
Irinotecan—Nausea—Prednisolone—hematologic cancer	4.95e-06	6.52e-05	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—hematologic cancer	4.89e-06	6.44e-05	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—hematologic cancer	4.88e-06	6.43e-05	CcSEcCtD
Irinotecan—Vomiting—Triamcinolone—hematologic cancer	4.87e-06	6.42e-05	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—hematologic cancer	4.84e-06	6.38e-05	CcSEcCtD
Irinotecan—Rash—Triamcinolone—hematologic cancer	4.83e-06	6.36e-05	CcSEcCtD
Irinotecan—Dermatitis—Triamcinolone—hematologic cancer	4.83e-06	6.36e-05	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—hematologic cancer	4.82e-06	6.35e-05	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—hematologic cancer	4.82e-06	6.35e-05	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—hematologic cancer	4.81e-06	6.34e-05	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—hematologic cancer	4.8e-06	6.33e-05	CcSEcCtD
Irinotecan—Headache—Triamcinolone—hematologic cancer	4.8e-06	6.32e-05	CcSEcCtD
Irinotecan—Abdominal pain—Prednisone—hematologic cancer	4.78e-06	6.31e-05	CcSEcCtD
Irinotecan—Body temperature increased—Prednisone—hematologic cancer	4.78e-06	6.31e-05	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—hematologic cancer	4.77e-06	6.29e-05	CcSEcCtD
Irinotecan—Diarrhoea—Dexamethasone—hematologic cancer	4.76e-06	6.27e-05	CcSEcCtD
Irinotecan—Diarrhoea—Betamethasone—hematologic cancer	4.76e-06	6.27e-05	CcSEcCtD
Irinotecan—Oedema—Epirubicin—hematologic cancer	4.73e-06	6.24e-05	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—hematologic cancer	4.73e-06	6.24e-05	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—hematologic cancer	4.73e-06	6.23e-05	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—hematologic cancer	4.72e-06	6.22e-05	CcSEcCtD
Irinotecan—Infection—Epirubicin—hematologic cancer	4.7e-06	6.2e-05	CcSEcCtD
Irinotecan—Cough—Doxorubicin—hematologic cancer	4.68e-06	6.17e-05	CcSEcCtD
Irinotecan—Shock—Epirubicin—hematologic cancer	4.66e-06	6.14e-05	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—hematologic cancer	4.64e-06	6.12e-05	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—hematologic cancer	4.64e-06	6.11e-05	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—hematologic cancer	4.63e-06	6.11e-05	CcSEcCtD
Irinotecan—Dizziness—Betamethasone—hematologic cancer	4.6e-06	6.06e-05	CcSEcCtD
Irinotecan—Dizziness—Dexamethasone—hematologic cancer	4.6e-06	6.06e-05	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—hematologic cancer	4.58e-06	6.03e-05	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—hematologic cancer	4.58e-06	6.03e-05	CcSEcCtD
Irinotecan—Nausea—Triamcinolone—hematologic cancer	4.55e-06	6e-05	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—hematologic cancer	4.54e-06	5.99e-05	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—hematologic cancer	4.51e-06	5.95e-05	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—hematologic cancer	4.51e-06	5.95e-05	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—hematologic cancer	4.51e-06	5.94e-05	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—hematologic cancer	4.5e-06	5.93e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisone—hematologic cancer	4.46e-06	5.88e-05	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—hematologic cancer	4.45e-06	5.87e-05	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—hematologic cancer	4.42e-06	5.83e-05	CcSEcCtD
Irinotecan—Vomiting—Dexamethasone—hematologic cancer	4.42e-06	5.82e-05	CcSEcCtD
Irinotecan—Vomiting—Betamethasone—hematologic cancer	4.42e-06	5.82e-05	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—hematologic cancer	4.42e-06	5.82e-05	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—hematologic cancer	4.4e-06	5.79e-05	CcSEcCtD
Irinotecan—Rash—Betamethasone—hematologic cancer	4.38e-06	5.77e-05	CcSEcCtD
Irinotecan—Rash—Dexamethasone—hematologic cancer	4.38e-06	5.77e-05	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—hematologic cancer	4.38e-06	5.77e-05	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—hematologic cancer	4.38e-06	5.77e-05	CcSEcCtD
Irinotecan—Dermatitis—Betamethasone—hematologic cancer	4.38e-06	5.77e-05	CcSEcCtD
Irinotecan—Dermatitis—Dexamethasone—hematologic cancer	4.38e-06	5.77e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.37e-06	5.75e-05	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—hematologic cancer	4.36e-06	5.75e-05	CcSEcCtD
Irinotecan—Headache—Dexamethasone—hematologic cancer	4.35e-06	5.74e-05	CcSEcCtD
Irinotecan—Headache—Betamethasone—hematologic cancer	4.35e-06	5.74e-05	CcSEcCtD
Irinotecan—Infection—Doxorubicin—hematologic cancer	4.35e-06	5.73e-05	CcSEcCtD
Irinotecan—Asthenia—Prednisone—hematologic cancer	4.34e-06	5.72e-05	CcSEcCtD
Irinotecan—Pain—Methotrexate—hematologic cancer	4.33e-06	5.7e-05	CcSEcCtD
Irinotecan—Shock—Doxorubicin—hematologic cancer	4.31e-06	5.68e-05	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—hematologic cancer	4.3e-06	5.66e-05	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—hematologic cancer	4.29e-06	5.65e-05	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—hematologic cancer	4.28e-06	5.64e-05	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—hematologic cancer	4.25e-06	5.6e-05	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—hematologic cancer	4.23e-06	5.58e-05	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—hematologic cancer	4.22e-06	5.56e-05	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—hematologic cancer	4.21e-06	5.55e-05	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—hematologic cancer	4.18e-06	5.5e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—hematologic cancer	4.17e-06	5.49e-05	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—hematologic cancer	4.17e-06	5.49e-05	CcSEcCtD
Irinotecan—Diarrhoea—Prednisone—hematologic cancer	4.14e-06	5.46e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—hematologic cancer	4.14e-06	5.45e-05	CcSEcCtD
Irinotecan—Nausea—Betamethasone—hematologic cancer	4.13e-06	5.44e-05	CcSEcCtD
Irinotecan—Nausea—Dexamethasone—hematologic cancer	4.13e-06	5.44e-05	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—hematologic cancer	4.12e-06	5.42e-05	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—hematologic cancer	4.09e-06	5.39e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.09e-06	5.39e-05	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—hematologic cancer	4.08e-06	5.38e-05	CcSEcCtD
Irinotecan—Constipation—Epirubicin—hematologic cancer	4.05e-06	5.33e-05	CcSEcCtD
Irinotecan—Pain—Epirubicin—hematologic cancer	4.05e-06	5.33e-05	CcSEcCtD
Irinotecan—Dizziness—Prednisone—hematologic cancer	4e-06	5.27e-05	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—hematologic cancer	4e-06	5.27e-05	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—hematologic cancer	4e-06	5.27e-05	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—hematologic cancer	3.96e-06	5.22e-05	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—hematologic cancer	3.93e-06	5.18e-05	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—hematologic cancer	3.91e-06	5.15e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—hematologic cancer	3.9e-06	5.14e-05	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—hematologic cancer	3.89e-06	5.13e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—hematologic cancer	3.87e-06	5.1e-05	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—hematologic cancer	3.86e-06	5.08e-05	CcSEcCtD
Irinotecan—Vomiting—Prednisone—hematologic cancer	3.85e-06	5.07e-05	CcSEcCtD
Irinotecan—Rash—Prednisone—hematologic cancer	3.82e-06	5.03e-05	CcSEcCtD
Irinotecan—Dermatitis—Prednisone—hematologic cancer	3.81e-06	5.02e-05	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—hematologic cancer	3.81e-06	5.02e-05	CcSEcCtD
Irinotecan—Headache—Prednisone—hematologic cancer	3.79e-06	5e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.78e-06	4.98e-05	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—hematologic cancer	3.78e-06	4.98e-05	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—hematologic cancer	3.75e-06	4.94e-05	CcSEcCtD
Irinotecan—Pain—Doxorubicin—hematologic cancer	3.75e-06	4.94e-05	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—hematologic cancer	3.74e-06	4.93e-05	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—hematologic cancer	3.74e-06	4.93e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—hematologic cancer	3.73e-06	4.91e-05	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—hematologic cancer	3.63e-06	4.78e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—hematologic cancer	3.61e-06	4.76e-05	CcSEcCtD
Irinotecan—Nausea—Prednisone—hematologic cancer	3.6e-06	4.74e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.58e-06	4.72e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—hematologic cancer	3.49e-06	4.6e-05	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—hematologic cancer	3.46e-06	4.56e-05	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—hematologic cancer	3.46e-06	4.56e-05	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—hematologic cancer	3.46e-06	4.56e-05	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—hematologic cancer	3.4e-06	4.48e-05	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—hematologic cancer	3.35e-06	4.41e-05	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—hematologic cancer	3.24e-06	4.27e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—hematologic cancer	3.23e-06	4.25e-05	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—hematologic cancer	3.22e-06	4.24e-05	CcSEcCtD
Irinotecan—Rash—Methotrexate—hematologic cancer	3.19e-06	4.2e-05	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—hematologic cancer	3.19e-06	4.2e-05	CcSEcCtD
Irinotecan—Headache—Methotrexate—hematologic cancer	3.17e-06	4.18e-05	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—hematologic cancer	3.14e-06	4.14e-05	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—hematologic cancer	3.13e-06	4.13e-05	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—hematologic cancer	3.01e-06	3.97e-05	CcSEcCtD
Irinotecan—Nausea—Methotrexate—hematologic cancer	3e-06	3.96e-05	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—hematologic cancer	3e-06	3.95e-05	CcSEcCtD
Irinotecan—Rash—Epirubicin—hematologic cancer	2.98e-06	3.93e-05	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—hematologic cancer	2.98e-06	3.93e-05	CcSEcCtD
Irinotecan—Headache—Epirubicin—hematologic cancer	2.97e-06	3.91e-05	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—hematologic cancer	2.9e-06	3.82e-05	CcSEcCtD
Irinotecan—Nausea—Epirubicin—hematologic cancer	2.81e-06	3.71e-05	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—hematologic cancer	2.79e-06	3.67e-05	CcSEcCtD
Irinotecan—Rash—Doxorubicin—hematologic cancer	2.76e-06	3.64e-05	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—hematologic cancer	2.76e-06	3.64e-05	CcSEcCtD
Irinotecan—Headache—Doxorubicin—hematologic cancer	2.74e-06	3.62e-05	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—hematologic cancer	2.6e-06	3.43e-05	CcSEcCtD
Irinotecan—ABCC1—Disease—MAP2K1—hematologic cancer	1.04e-06	3.04e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CD—hematologic cancer	1.03e-06	3.02e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.03e-06	3.02e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYCS—hematologic cancer	1.03e-06	3.02e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—MTHFR—hematologic cancer	1.03e-06	3.02e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	1.02e-06	3e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—MTHFR—hematologic cancer	1.02e-06	2.99e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ENO2—hematologic cancer	1.02e-06	2.99e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CG—hematologic cancer	1.02e-06	2.99e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CG—hematologic cancer	1.02e-06	2.99e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CB—hematologic cancer	1.01e-06	2.96e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1e-06	2.95e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CREBBP—hematologic cancer	9.95e-07	2.92e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.94e-07	2.92e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FHL2—hematologic cancer	9.93e-07	2.91e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTT1—hematologic cancer	9.88e-07	2.9e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGF2—hematologic cancer	9.87e-07	2.9e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CG—hematologic cancer	9.82e-07	2.88e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.79e-07	2.87e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AGRN—hematologic cancer	9.74e-07	2.86e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	9.74e-07	2.86e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3R1—hematologic cancer	9.74e-07	2.86e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SDC1—hematologic cancer	9.66e-07	2.83e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.59e-07	2.81e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CG—hematologic cancer	9.58e-07	2.81e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—JAK2—hematologic cancer	9.46e-07	2.78e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CREBBP—hematologic cancer	9.44e-07	2.77e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CREBBP—hematologic cancer	9.44e-07	2.77e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CD—hematologic cancer	9.44e-07	2.77e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CD44—hematologic cancer	9.37e-07	2.75e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NQO1—hematologic cancer	9.37e-07	2.75e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	9.33e-07	2.74e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—hematologic cancer	9.32e-07	2.73e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTP1—hematologic cancer	9.28e-07	2.72e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—hematologic cancer	9.26e-07	2.72e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.25e-07	2.71e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MDM2—hematologic cancer	9.24e-07	2.71e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—IDH2—hematologic cancer	9.23e-07	2.71e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HMMR—hematologic cancer	9.23e-07	2.71e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.18e-07	2.69e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CREBBP—hematologic cancer	9.11e-07	2.67e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTP1—hematologic cancer	9.08e-07	2.66e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—hematologic cancer	9.03e-07	2.65e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MTOR—hematologic cancer	8.99e-07	2.64e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CB—hematologic cancer	8.99e-07	2.64e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD4—hematologic cancer	8.97e-07	2.63e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CD—hematologic cancer	8.95e-07	2.63e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CD—hematologic cancer	8.95e-07	2.63e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3R1—hematologic cancer	8.91e-07	2.61e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CREBBP—hematologic cancer	8.88e-07	2.6e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYCS—hematologic cancer	8.87e-07	2.6e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—hematologic cancer	8.84e-07	2.59e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—hematologic cancer	8.84e-07	2.59e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HSP90AA1—hematologic cancer	8.81e-07	2.58e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—hematologic cancer	8.79e-07	2.58e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.68e-07	2.55e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.66e-07	2.54e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CREBBP—hematologic cancer	8.65e-07	2.54e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—hematologic cancer	8.64e-07	2.54e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CD—hematologic cancer	8.63e-07	2.53e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—hematologic cancer	8.61e-07	2.53e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—hematologic cancer	8.59e-07	2.52e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—hematologic cancer	8.57e-07	2.51e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—hematologic cancer	8.53e-07	2.5e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NCOR1—hematologic cancer	8.53e-07	2.5e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—hematologic cancer	8.52e-07	2.5e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3R1—hematologic cancer	8.46e-07	2.48e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3R1—hematologic cancer	8.46e-07	2.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ACP5—hematologic cancer	8.44e-07	2.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CA9—hematologic cancer	8.44e-07	2.48e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—hematologic cancer	8.43e-07	2.47e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CD—hematologic cancer	8.42e-07	2.47e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NCOR1—hematologic cancer	8.34e-07	2.45e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—hematologic cancer	8.34e-07	2.45e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.33e-07	2.44e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—hematologic cancer	8.31e-07	2.44e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—hematologic cancer	8.31e-07	2.44e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CB—hematologic cancer	8.23e-07	2.41e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CD44—hematologic cancer	8.21e-07	2.41e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NQO1—hematologic cancer	8.21e-07	2.41e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	8.21e-07	2.41e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3R1—hematologic cancer	8.15e-07	2.39e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—hematologic cancer	8.1e-07	2.38e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SRC—hematologic cancer	8.08e-07	2.37e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CREBBP—hematologic cancer	8.01e-07	2.35e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3R1—hematologic cancer	7.95e-07	2.33e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CREBBP—hematologic cancer	7.94e-07	2.33e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—IDH1—hematologic cancer	7.94e-07	2.33e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.93e-07	2.33e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—hematologic cancer	7.87e-07	2.31e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.85e-07	2.3e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TXN—hematologic cancer	7.85e-07	2.3e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.85e-07	2.3e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—hematologic cancer	7.82e-07	2.29e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CB—hematologic cancer	7.81e-07	2.29e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CB—hematologic cancer	7.81e-07	2.29e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—hematologic cancer	7.78e-07	2.28e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—hematologic cancer	7.77e-07	2.28e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYCS—hematologic cancer	7.77e-07	2.28e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—hematologic cancer	7.77e-07	2.28e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	7.75e-07	2.27e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HSP90AA1—hematologic cancer	7.72e-07	2.26e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.68e-07	2.25e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CD—hematologic cancer	7.6e-07	2.23e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.56e-07	2.22e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MTHFR—hematologic cancer	7.54e-07	2.21e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CD—hematologic cancer	7.53e-07	2.21e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CB—hematologic cancer	7.53e-07	2.21e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—hematologic cancer	7.5e-07	2.2e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—hematologic cancer	7.44e-07	2.18e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—hematologic cancer	7.43e-07	2.18e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—hematologic cancer	7.41e-07	2.17e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—hematologic cancer	7.4e-07	2.17e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.38e-07	2.17e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MTHFR—hematologic cancer	7.37e-07	2.16e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CB—hematologic cancer	7.34e-07	2.15e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—hematologic cancer	7.22e-07	2.12e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SRC—hematologic cancer	7.2e-07	2.11e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—hematologic cancer	7.18e-07	2.11e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NCOR1—hematologic cancer	7.18e-07	2.11e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.18e-07	2.11e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.18e-07	2.11e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3R1—hematologic cancer	7.17e-07	2.1e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	7.15e-07	2.1e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3R1—hematologic cancer	7.11e-07	2.09e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—hematologic cancer	7.11e-07	2.09e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALOX5—hematologic cancer	7e-07	2.05e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—hematologic cancer	6.95e-07	2.04e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—hematologic cancer	6.93e-07	2.03e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—hematologic cancer	6.85e-07	2.01e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—hematologic cancer	6.78e-07	1.99e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NUP98—hematologic cancer	6.78e-07	1.99e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—hematologic cancer	6.74e-07	1.98e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—hematologic cancer	6.74e-07	1.98e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—hematologic cancer	6.69e-07	1.96e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—hematologic cancer	6.64e-07	1.95e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CB—hematologic cancer	6.62e-07	1.94e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.58e-07	1.93e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.58e-07	1.93e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CB—hematologic cancer	6.56e-07	1.93e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NUP214—hematologic cancer	6.53e-07	1.92e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—hematologic cancer	6.5e-07	1.91e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—hematologic cancer	6.45e-07	1.89e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—hematologic cancer	6.44e-07	1.89e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—hematologic cancer	6.43e-07	1.89e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—hematologic cancer	6.43e-07	1.89e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTR—hematologic cancer	6.4e-07	1.88e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.4e-07	1.88e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—hematologic cancer	6.37e-07	1.87e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MTHFR—hematologic cancer	6.35e-07	1.86e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—hematologic cancer	6.34e-07	1.86e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—hematologic cancer	6.34e-07	1.86e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NCOR1—hematologic cancer	6.29e-07	1.85e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—hematologic cancer	6.29e-07	1.85e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO2—hematologic cancer	6.28e-07	1.84e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—hematologic cancer	6.2e-07	1.82e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—hematologic cancer	6.19e-07	1.82e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—hematologic cancer	6.18e-07	1.81e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—hematologic cancer	6.14e-07	1.8e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.09e-07	1.79e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—hematologic cancer	6.05e-07	1.77e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—hematologic cancer	5.96e-07	1.75e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SDC1—hematologic cancer	5.95e-07	1.75e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—hematologic cancer	5.94e-07	1.74e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—hematologic cancer	5.89e-07	1.73e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CREBBP—hematologic cancer	5.87e-07	1.72e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CREBBP—hematologic cancer	5.74e-07	1.68e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—hematologic cancer	5.72e-07	1.68e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—hematologic cancer	5.68e-07	1.67e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—hematologic cancer	5.67e-07	1.66e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.59e-07	1.64e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CD—hematologic cancer	5.57e-07	1.63e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MTHFR—hematologic cancer	5.56e-07	1.63e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—hematologic cancer	5.5e-07	1.61e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—hematologic cancer	5.48e-07	1.61e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—hematologic cancer	5.46e-07	1.6e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CD—hematologic cancer	5.44e-07	1.6e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—hematologic cancer	5.41e-07	1.59e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—hematologic cancer	5.37e-07	1.58e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—hematologic cancer	5.33e-07	1.56e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3R1—hematologic cancer	5.26e-07	1.54e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—hematologic cancer	5.2e-07	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3R1—hematologic cancer	5.14e-07	1.51e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—hematologic cancer	5.07e-07	1.49e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CD44—hematologic cancer	5.06e-07	1.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NQO1—hematologic cancer	5.06e-07	1.48e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—hematologic cancer	5.02e-07	1.47e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—hematologic cancer	5.01e-07	1.47e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CREBBP—hematologic cancer	4.94e-07	1.45e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CB—hematologic cancer	4.85e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—hematologic cancer	4.85e-07	1.42e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYCS—hematologic cancer	4.79e-07	1.4e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—hematologic cancer	4.76e-07	1.4e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—hematologic cancer	4.76e-07	1.4e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.76e-07	1.4e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CB—hematologic cancer	4.75e-07	1.39e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CD—hematologic cancer	4.69e-07	1.38e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.67e-07	1.37e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—hematologic cancer	4.59e-07	1.35e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—hematologic cancer	4.48e-07	1.31e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—hematologic cancer	4.47e-07	1.31e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3R1—hematologic cancer	4.43e-07	1.3e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	4.36e-07	1.28e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CREBBP—hematologic cancer	4.33e-07	1.27e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.22e-07	1.24e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—hematologic cancer	4.19e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.11e-07	1.21e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—hematologic cancer	4.1e-07	1.2e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—hematologic cancer	4.1e-07	1.2e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CB—hematologic cancer	4.09e-07	1.2e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—hematologic cancer	4.06e-07	1.19e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—hematologic cancer	4.04e-07	1.18e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—hematologic cancer	4e-07	1.17e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—hematologic cancer	4e-07	1.17e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.99e-07	1.17e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—hematologic cancer	3.91e-07	1.15e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—hematologic cancer	3.89e-07	1.14e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—hematologic cancer	3.89e-07	1.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.88e-07	1.14e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.88e-07	1.14e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.88e-07	1.14e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—hematologic cancer	3.75e-07	1.1e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—hematologic cancer	3.65e-07	1.07e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.58e-07	1.05e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—hematologic cancer	3.56e-07	1.04e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—hematologic cancer	3.53e-07	1.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.43e-07	1.01e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—hematologic cancer	3.37e-07	9.88e-06	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—hematologic cancer	3.3e-07	9.67e-06	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—hematologic cancer	3.27e-07	9.59e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—hematologic cancer	3.09e-07	9.08e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—hematologic cancer	2.96e-07	8.68e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—hematologic cancer	2.95e-07	8.66e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.89e-07	8.49e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.88e-07	8.45e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.67e-07	7.83e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.53e-07	7.42e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—hematologic cancer	2.5e-07	7.33e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—hematologic cancer	2.49e-07	7.31e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—hematologic cancer	2.42e-07	7.09e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.39e-07	7.01e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—hematologic cancer	2.36e-07	6.93e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.21e-07	6.47e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.18e-07	6.4e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—hematologic cancer	2.04e-07	5.97e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—hematologic cancer	1.91e-07	5.59e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—hematologic cancer	1.82e-07	5.33e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—hematologic cancer	1.78e-07	5.23e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.34e-07	3.94e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—hematologic cancer	1.1e-07	3.22e-06	CbGpPWpGaD
